Loading...
Beijing Chunlizhengda Medical Instruments Co., Ltd.
1858.HK•HKSE
Healthcare
Medical - Devices
HK$15.40
HK$-0.41(-2.59%)

The company's financials show resilient growth, with revenue advancing from $416.37M in Q4 2023 to $126.48M in Q3 2024. Gross profit remained healthy with margins at 62% in Q3 2024 compared to 72% in Q4 2023. Operating income hit -$20.81M last quarter, sustaining a consistent -16% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at -$16.90M. Net income dropped to -$17.87M, while earnings per share reached -$0.05. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan